In recent weeks, the pan-European STOXX Europe 600 Index has experienced modest gains amid easing geopolitical tensions and strong corporate earnings, despite pressures from potential U.S. tariff increases on EU goods. As investors navigate this landscape, growth companies with high insider ownership can be appealing due to their potential for alignment of interests between management and shareholders, offering a unique edge in today’s market environment.
Top 10 Growth Companies With High Insider Ownership In Europe
Underneath we present a selection of stocks filtered out by our screen.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Oryzon Genomics S.A. is a clinical-stage biopharmaceutical company focused on developing epigenetics-based therapeutics for cancer and CNS, oncology, and hematology disorders, with a market cap of €216.73 million.
Operations: The company generates its revenue primarily from the biotechnology segment, amounting to €10.93 million.
Insider Ownership: 13.9%
Oryzon Genomics shows promising growth potential, with earnings forecast to grow 51.67% annually and revenue expected to increase by 47.9% per year, outpacing the Spanish market. Despite recent net losses of EUR 2.61 million for 2025, sales improved significantly from EUR 7.36 million to EUR 10.93 million year-over-year. The company is advancing its clinical pipeline with significant developments in iadademstat trials and strategic leadership appointments enhancing its CNS programs’ capabilities.
BME:ORY Ownership Breakdown as at May 2026
Simply Wall St Growth Rating: ★★★★★☆
Overview: Med Life S.A. is a private healthcare provider offering integrated medical services through its clinics and hospitals in Romania, with a market cap of RON6.35 billion.
Operations: The company’s revenue is primarily derived from its clinics (RON1.18 billion), hospitals (RON883.26 million), corporate services (RON306.92 million), laboratories (RON352.04 million), pharmacies (RON78.40 million), and stomatology services (RON122.21 million).
Insider Ownership: 36.5%
Med Life demonstrates potential as a growth company with high insider ownership, despite challenges. Its revenue is forecast to grow at 9.5% annually, outpacing the Romanian market average of 5.2%. However, profit margins have declined from 0.9% to 0.4%, and net income fell to RON 11.6 million in 2025 from RON 25.04 million the previous year. Earnings are expected to grow significantly at an annual rate of over 62%, though interest coverage remains a concern.
BVB:M Earnings and Revenue Growth as at May 2026
Simply Wall St Growth Rating: ★★★★★★
Overview: Circus SE is a technology company that develops and delivers autonomous solutions for the food service market, with a market cap of €214.73 million.
Operations: The company generates its revenue primarily from the Industrial Automation & Controls segment, amounting to €0.88 million.
Insider Ownership: 21.9%
Circus SE is positioned for significant growth, with revenue projected to expand 45.5% annually, surpassing the German market’s average. Despite past shareholder dilution and a volatile share price, Circus is expected to achieve profitability within three years and boasts a high forecasted return on equity of 105.7%. Recent strategic alliances and successful financing initiatives underscore its expanding deployment of AI robotics in defence sectors, including contracts with the German and Lithuanian armed forces.
XTRA:CA1 Ownership Breakdown as at May 2026
Next Steps
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Companies discussed in this article include BME:ORY BVB:M and XTRA:CA1.
